Ghana and Zambia have rejected or halted proposed U.S. health deals, citing significant concerns over the required sharing of sensitive national health data.
- Zambia halted a funding agreement worth more than $1 billion.
- Ghana rejected a deal after negotiations that began in November.
- Approximately 17 African nations have accepted the new U.S. health terms.
Concerns Over National Health Data
In February, Zambia halted a proposed health funding agreement exceeding $1 billion. The government cited concerns that specific clauses in the draft did not align with national interests.
The agreement was designed to provide funding over five years to combat malaria and HIV/AIDS, improve maternal and child health services, and strengthen epidemic preparedness.
Zambia specifically opposed requirements for long-term access to national health data, arguing that such access could expose sensitive population-level information.
Ghana’s Rejection of U.S. Health Deals
Ghana has cited similar data privacy concerns regarding its own proposed health agreement with the United States. The current administration has rejected the requirement to share sensitive health data.
Negotiations for a $109 health deal spread over five years began in November of last year. While initial conversations were routine, the process faced increased pressure toward the end.
The U.S. set a deadline of April 24 to finalize the negotiations, but Ghana ultimately concluded it could not accept the proposed terms.
According to government foreign aid records, the U.S. disbursed $219 million in foreign aid to Ghana for 2024, prior to the 2025 resumption of Donald Trump’s office and subsequent global cuts to USAID.
As of March, around 17 African countries have accepted the new health deals, including Kenya, Rwanda, Nigeria, Burkina Faso, and the Democratic Republic of Congo.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
